Minoryx Therapeutics announces early completion of patient randomization in the ADVANCE trial
Genoscience Pharma named EuropaBio’s Most Innovative European Biotech SME for 2018
iDD biotech receives second milestone payment from Genmab with enrolment of fifth patient in Gen1029 safety trial
Yposkesi enters into agreement in principle for strategic partnership with Axovant to expand Axovant’s gene therapy manufacturing capacity
Domain Therapeutics signs a multi-target research collaboration and license agreement with Boehringer Ingelheim
Alizé Pharma 3 moves forward with building a transatlantic biopharmaceutical company focused on rare endocrine and metabolic diseases
GamaMabs Pharma to present new data on GM102 at two upcoming scientific conferences in November
Nosopharm appoints Dr Sarah Gould as chief development officer
